Jazz Pharmaceuticals (NASDAQ:JAZZ) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Jazz Pharmaceuticals beat estimated earnings by 15.98%, reporting an EPS of $4.21 versus an estimate of $3.63.
Revenue was up $231.21 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.89 which was followed by a 3.27% increase in the share price the next day.
Here's a look at Jazz Pharmaceuticals's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | 3.31 | 3.42 | 3.74 | 4.2 |
| EPS Actual | 4.20 | 3.90 | 3.92 | 4 |
| Revenue Estimate | 832.52M | 735.62M | 611.49M | 639.55M |
| Revenue Actual | 838.12M | 751.81M | 607.58M | 665.52M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
